A71915 (trifluoroacetate salt) 1 mg | ≥98% Cayman Chemical A GC-A antagonist More Information Supplier Page × A71915 (trifluoroacetate salt)
ARV-471 5 mg | ≥98% Cayman Chemical A PROTAC that drives ER degradation More Information Supplier Page × ARV-471
ARV-471 10 mg | ≥98% Cayman Chemical A PROTAC that drives ER degradation More Information Supplier Page × ARV-471
ARV-471 1 mg | ≥98% Cayman Chemical A PROTAC that drives ER degradation More Information Supplier Page × ARV-471
Zopiclone Impurity B 500 mg | ≥95% Cayman Chemical A potential impurity found in commercial preparations of zopiclone More Information Supplier Page × Zopiclone Impurity B
Zopiclone Impurity B 5 g | ≥95% Cayman Chemical A potential impurity found in commercial preparations of zopiclone More Information Supplier Page × Zopiclone Impurity B
Zopiclone Impurity B 250 mg | ≥95% Cayman Chemical A potential impurity found in commercial preparations of zopiclone More Information Supplier Page × Zopiclone Impurity B
Zopiclone Impurity B 1 g | ≥95% Cayman Chemical A potential impurity found in commercial preparations of zopiclone More Information Supplier Page × Zopiclone Impurity B
Zolpidic Acid 500 mg | ≥98% Cayman Chemical An antioxidant and intermediate in the synthesis of zolpidem More Information Supplier Page × Zolpidic Acid
Zolpidic Acid 5 g | ≥98% Cayman Chemical An antioxidant and intermediate in the synthesis of zolpidem More Information Supplier Page × Zolpidic Acid
